Interferon Lambda Therapy for COVID-19

Stopped Due to the number of competing trials at their site, the study team has closed enrollment and withdrawn this trial.

Conditions

• SARS-CoV-2

Interventions

• DRUG: Peginterferon Lambda-1A

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

• [object Object]